B. Decock

1.2k citations
17 papers · 993 indexed · h-index 13

B. Decock

17 papers receiving 974 citations

Peers

B. Decock
Comparison fields: 5 of 80
  • Immunology and Allergy 186
  • Immunology 356
  • Cell Biology 206
  • Oncology 248
  • Molecular Biology 469
Replace Vincent O’Brien with:
Vincent O’Brien United Kingdom
Odile Berthier‐Vergnes France
Gail Flaggs United States
Naoya Tsurushita United States
Fabrice Allain France
J A Wyke United Kingdom
A.-P.J. Huovila Finland
Roger G. E. Palfree Canada
Wolfgang Nagel Germany
Randall N. Knibbs United States
B. Decock relative to Vincent O’Brien United Kingdom Vincent O’Brien's profile →
Citations per field
00.5×1.7×
Vincent O’Brien · 1×
Citations per year

Countries citing papers authored by B. Decock

Since Specialization
Citations

This map shows the geographic impact of B. Decock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Decock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Decock more than expected).

Fields of papers citing papers by B. Decock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Decock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Decock. The network helps show where B. Decock may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. Decock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Decock Line = papers co-authored together B. Decock links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 199119
2 1991107
3 199126
4 199138
5 19908
6 199029
7 199079
8 1990236
9 199022
10 198972
11 1989125
12 198991
13
Interferon-gamma is cytotoxic for normal mouse fibroblasts: enhancement by tumor necrosis factor and interleukin 1.
198916
14 19891
15 1988117
16 19886
17 19871

About B. Decock

B. Decock is a scholar working on Immunology and Allergy, Hematology and Genetics, having authored 17 papers that have together received 993 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Cell Adhesion Molecules Research (4 papers), Chemokine receptors and signaling (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Glycosylation and Glycoproteins Research (2 papers), Respiratory viral infections research (2 papers), Platelet Disorders and Treatments (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology and Allergy (186 citations), Immunology (356 citations) and Cell Biology (206 citations). B. Decock has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Jo Van Damme, René Conings, Alfons Billiau, J J Cassiman, Peter Marynen, Jean‐Pierre Lenaerts, Herman Van den Berghe, Gregory David, Jozef Van Beeumen and Ghislain Opdenakker. Their work appears in journals such as European Journal of Biochemistry, European Journal of Immunology, The Journal of Cell Biology, The Journal of Immunology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026